AT Impf

AT Impf

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Germany, Munich


This investor is located in Europe, Germany. The primary office of this Corporate Investor is located in Munich.

Moreover, a start-up needs to be 16-20 years old to get investment from this fund. Among their most successful investment fields, we have identified Biotechnology, Therapeutics. Also, because of its portfolio diversification tendency, we can highlight 2 more industries for this fund. The country of its foundation and the country of its most frequent investments coincides - Germany. Isarna Therapeutics is amongst the various portfolio company of this fund.

The usual method for the fund is to invest in rounds with 3-4 other investors. Besides AT Impf, start-ups are typically funded by Wellington Partners, MIG AG, dievini Hopp Biotech Holding and 3 more VCs. Other VCs who often invest in the same rounds are dievini Hopp Biotech Holding, Wellington Partners, MIG AG. The investors in the following rounds are usually dievini Hopp Biotech Holding, Wellington Partners, Amgen.

In 2014, the fund's activity was at its peak. Deals in the range of 10 - 50 millions dollars are most common for this fund. The fund usually participates in less than 2 investment rounds per year.

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first_initial last, first_initial '0' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

40.0% of cases

Funds Investing in Previous

Wellington Partners, MIG AG, dievini Hopp Biotech Holding

Funds Investing in Following

dievini Hopp Biotech Holding, Wellington Partners, Amgen

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: